Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yanli Yang

Showing results (271-280 of 284) with videos related to

Pageof 29
Sort By:
Plos One|July 18, 2013
Label free fragment screening using surface plasmon resonance as a tool for fragment finding - analyzing parkin, a difficult CNS targetKarin Regnström, Jiangli Yan, Lan Nguyen, et al.
Molecular Pharmacology|March 31, 2026
Corrigendum to "A subunit-selective negative allosteric modulator of GluN1/GluN3A glycine-activated receptor" [Molecular Pharmacology 108 (2026) 100104]Leon Jacobs, TrangKimberly T Nguyen, Adam McCallum, et al.
Molecular Pharmacology|February 19, 2026
A subunit-selective negative allosteric modulator of GluN1/GluN3A glycine-activated receptorLeon Jacobs, TrangKimberly T Nguyen, Adam McCallum, et al.
Scientific Reports|October 14, 2024
Effectiveness and safety of azvudine versus nirmatrelvir-ritonavir in adult patients infected with COVID-19 omicron strains: a retrospective study in BeijingHuaiya Xie, Yaqi Wang, Yan Xu, et al.
ACS Pharmacology & Translational Science|September 19, 2025
Next-Generation Lipid Prodrugs Orally Deliver Tenofovir via Enhanced Chylomicron IncorporationHannah Beth Gold, Nicole Pribut, Esther L Outtrim, et al.
Nature Communications|May 3, 2025
Leveraging neonatal Fc receptor (FcRn) to enhance antibody transport across the blood brain barrierJulien Lafrance-Vanasse, Shraddha S Sadekar, Yanli Yang, et al.
Cell Reports. Medicine|November 20, 2025
Precision prediction of venetoclax-azacitidine treatment efficacy in acute myeloid leukemia via integrative drug screening and machine learningPeng Jin, Dan Wang, Jie Shen, et al.
Chest|February 21, 2023
Determinants of Progression and Mortality in LymphangioleiomyomatosisWenshuai Xu, Chenlu Yang, Chongsheng Cheng, et al.
Experimental Hematology & Oncology|October 1, 2025
Phase II study of zevorcabtagene autoleucel, a fully human BCMA-targeting CAR T cell therapy, in patients with relapsed/refractory multiple myelomaWenming Chen, Chengcheng Fu, Baijun Fang, et al.
Mabs|June 4, 2019
Tetravalent biepitopic targeting enables intrinsic antibody agonism of tumor necrosis factor receptor superfamily membersYanli Yang, Sherry H Yeh, Shravan Madireddi, et al.
Pageof 29

Showing results (271-280 of 284) with videos related to

Sort By:
Pageof 29
Plos One|July 18, 2013
Label free fragment screening using surface plasmon resonance as a tool for fragment finding - analyzing parkin, a difficult CNS targetKarin Regnström, Jiangli Yan, Lan Nguyen, et al.
Molecular Pharmacology|March 31, 2026
Corrigendum to "A subunit-selective negative allosteric modulator of GluN1/GluN3A glycine-activated receptor" [Molecular Pharmacology 108 (2026) 100104]Leon Jacobs, TrangKimberly T Nguyen, Adam McCallum, et al.
Molecular Pharmacology|February 19, 2026
A subunit-selective negative allosteric modulator of GluN1/GluN3A glycine-activated receptorLeon Jacobs, TrangKimberly T Nguyen, Adam McCallum, et al.
Scientific Reports|October 14, 2024
Effectiveness and safety of azvudine versus nirmatrelvir-ritonavir in adult patients infected with COVID-19 omicron strains: a retrospective study in BeijingHuaiya Xie, Yaqi Wang, Yan Xu, et al.
ACS Pharmacology & Translational Science|September 19, 2025
Next-Generation Lipid Prodrugs Orally Deliver Tenofovir via Enhanced Chylomicron IncorporationHannah Beth Gold, Nicole Pribut, Esther L Outtrim, et al.
Nature Communications|May 3, 2025
Leveraging neonatal Fc receptor (FcRn) to enhance antibody transport across the blood brain barrierJulien Lafrance-Vanasse, Shraddha S Sadekar, Yanli Yang, et al.
Cell Reports. Medicine|November 20, 2025
Precision prediction of venetoclax-azacitidine treatment efficacy in acute myeloid leukemia via integrative drug screening and machine learningPeng Jin, Dan Wang, Jie Shen, et al.
Chest|February 21, 2023
Determinants of Progression and Mortality in LymphangioleiomyomatosisWenshuai Xu, Chenlu Yang, Chongsheng Cheng, et al.
Experimental Hematology & Oncology|October 1, 2025
Phase II study of zevorcabtagene autoleucel, a fully human BCMA-targeting CAR T cell therapy, in patients with relapsed/refractory multiple myelomaWenming Chen, Chengcheng Fu, Baijun Fang, et al.
Mabs|June 4, 2019
Tetravalent biepitopic targeting enables intrinsic antibody agonism of tumor necrosis factor receptor superfamily membersYanli Yang, Sherry H Yeh, Shravan Madireddi, et al.
Pageof 29